FASLG and COVID-19: Because higher levels of sFasL in the plasma of hospitalized COVID-19 patients correlate with the extent of CD4 T-cell apoptosis [27], we assessed the levels of sFasL in S-flow responders and nonresponders (not all patients were tested due to the limited available samples).